B-Cell Maturation Antigen (Bcma) Anti-Idiotypic Antibodies - EP4590708
EP4590708
- Filing Date
- Sep 18, 2023
- Status
- Pending
- Grant Date
- Jul 30, 2025
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP4590708A2 was granted to Pfizer on Jul 30, 2025 following the initial filing on Sep 18, 2023 under the application number The current legal status of the patent is Pending.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents